Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
18.31
-0.50 (-2.66%)
At close: Dec 5, 2025, 4:00 PM EST
18.31
0.00 (0.00%)
After-hours: Dec 5, 2025, 7:36 PM EST
Summit Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 14,120 | 13,160 | 1,829 | 897 | 263 | 387 | |
| Market Cap Growth | -4.27% | 619.43% | 103.94% | 241.23% | -32.01% | -28.06% | |
| Enterprise Value | 13,887 | 12,705 | 1,737 | 779 | 184 | 366 | |
| Last Close Price | 18.31 | 17.84 | 2.61 | 4.25 | 2.69 | 4.70 | |
| PS Ratio | - | - | - | 1272.24 | 145.30 | 449.56 | |
| PB Ratio | 70.90 | 33.85 | 23.54 | 7.08 | 3.16 | 4.87 | |
| P/TBV Ratio | 74.21 | 34.02 | 24.13 | 7.18 | 3.71 | 5.87 | |
| EV/Sales Ratio | - | - | - | 1105.42 | 101.96 | 425.47 | |
| Debt / Equity Ratio | 0.03 | 0.02 | 1.37 | 4.10 | 0.03 | 0.01 | |
| Asset Turnover | - | - | - | 0.00 | 0.02 | 0.01 | |
| Quick Ratio | 3.67 | 9.90 | 9.17 | 9.15 | 3.47 | 3.85 | |
| Current Ratio | 3.80 | 10.15 | 9.30 | 16.93 | 3.80 | 4.41 | |
| Return on Equity (ROE) | -292.49% | -94.89% | -601.85% | -75.05% | -108.89% | -66.57% | |
| Return on Assets (ROA) | -152.88% | -41.30% | -12.79% | -10.23% | -49.91% | -32.91% | |
| Return on Capital (ROIC) | -174.95% | -45.49% | -13.38% | -10.87% | -64.91% | -40.97% | |
| Return on Capital Employed (ROCE) | -475.20% | -53.60% | -48.60% | -10.20% | -98.20% | -63.40% | |
| Earnings Yield | -6.53% | -1.68% | -33.62% | -8.78% | -33.71% | -13.63% | |
| FCF Yield | -1.91% | -1.08% | -4.20% | -4.71% | -27.73% | -12.55% | |
| Buyback Yield / Dilution | -4.36% | -15.96% | -220.50% | -109.60% | -32.67% | -111.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.